SCNI
Scinai Immunotherapeutics
SCNI
SCNI
5 hedge funds and large institutions have $85.5K invested in Scinai Immunotherapeutics in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$26.6K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$22.9K |
| 3 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$4.39K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$6.56K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $27.5K | -$6.56K | -2,876 | -19% |
|
|
2
Citadel Advisors
Miami,
Florida
| $26.6K | +$26.6K | +11,599 | New |
|
|
3
Bank of Montreal
Toronto,
Ontario, Canada
| $22.9K | +$22.9K | +10,000 | New |
|
|
4
RhumbLine Advisers
Boston,
Massachusetts
| $7.98K | +$4.39K | +1,916 | +122% |
|
5
Morgan Stanley
New York
| $581 | – | – | – |
|